Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.
| Autor: | Wadhwa, Vivek K.1, Weston, Robin1, Parr, Nigel J.1 |
|---|---|
| Zdroj: | BJU International. Jun2011, Vol. 107 Issue 12, p1923-1929. 7p. 3 Charts, 3 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|